5 Massachusetts Biotechs That Tanked More Than 60% in 2017 Post author:Sam Post published:January 1, 2018 Post category:BioPharma This is definitely a list few, if any, companies want to be on. Source: BioSpace You Might Also Like Immunarray Enters Partnership With July 9, 2017 The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017 Veracyte Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis May 18, 2017
The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) September 28, 2017
Veracyte Announces Anthem Coverage For The Afirma Gene Expression Classifier For Use In Thyroid Cancer Diagnosis May 18, 2017
